the whole blood. After extraction, the DNA was subjected to HLA genotyping for HLA-A, -B, -C, -DRB1, and -DQB1 loci with the specific sequencing primers (CATB, HLA-SBT Kits, Shanghai, China). Informed consent was obtained from the subjects involved.The HLA-B*15:644 allele had one nucleotide change when compared to the HLA-B*15:17:01:02 allele in exon 4 at position 869 where T > A, resulting in an amino acid change of Glutamine to Arginine (Figure 1).The name HLA-B*15:644 has been officially assigned by the WHO Nomenclature Committee for Factors of the HLA System in September 2022 (submission number HWS10062642). 1 This follows the agreed policy that subjects to conditions stated in the most recent Nomenclature Report, names would be assigned to new sequences as they are identified. Lists of such names will be published in the following WHO Nomenclature Report. 2 AUTHOR CONTRIBUTIONS Zhuo-yue Shi, Yan-min Zhao, and Zhong-zheng Zheng: designed the study; Ke-ming Du: analyzed the data; Zhong-zheng Zheng, Ke-ming Du, Gong-qiang Wu, and Yan-min Zhao: wrote the manuscript; Zhongzheng Zheng provided genetic laboratory data. All authors read and approved the final version of the manuscript.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.